Suppr超能文献

Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype.

作者信息

He B, Tang Z Y, Liu K D, Zhou G

机构信息

Liver Cancer Institute, Shanghai Medical University, China.

出版信息

J Cancer Res Clin Oncol. 1996;122(12):763-6. doi: 10.1007/BF01209125.

Abstract

The polymerase chain reaction and HaeIII enzymatic digestion were used to study the seventh exon of the p53 gene in 29 primary and recurrent hepatomas in paraffin-embedded samples from 11 patients. The mutation rate of the p53 gene and its genotypes in samples of primary and recurrent tumours and multiple nodules were investigated. The cellular origins of hepatocellular carcinoma were analysed by p53 genotype. p53 mutation rates were found to be 69.0% (20/29) in the primary and recurrent tumours, 58.8% (10/17) in tumours with a single nodule and 83.3% (10/12) in tumours with multiple nodules. The p53 genotypes were found to be different in 6 pairs of primary and recurrent tumours, and another 5 pairs had the same p53 genotypes. The samples with multiple nodules in the same patients had the same p53 genotypes. Seven recurrences were of multicentric origin and four were of unicentric origin. It is suggested that the recurrent lesions developed from both unicentric and multicentric origins.

摘要

相似文献

1
Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype.
J Cancer Res Clin Oncol. 1996;122(12):763-6. doi: 10.1007/BF01209125.
2
Gene therapy for people with hepatocellular carcinoma.
Cochrane Database Syst Rev. 2024 Jun 4;6(6):CD013731. doi: 10.1002/14651858.CD013731.pub2.
4
Clinical implication of screening p53 gene mutations in head and neck squamous cell carcinomas.
J Cancer Res Clin Oncol. 1998;124(7):389-96. doi: 10.1007/s004320050188.
5
Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
Cochrane Database Syst Rev. 2015 Jan 26;1(1):CD006745. doi: 10.1002/14651858.CD006745.pub3.
7
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.
Cochrane Database Syst Rev. 2016 Mar 1;3(3):CD010360. doi: 10.1002/14651858.CD010360.pub2.
8
Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.
Cochrane Database Syst Rev. 2017 Mar 10;3(3):CD011649. doi: 10.1002/14651858.CD011649.pub2.
10
MAGE-1 and related MAGE gene expression may be associated with hepatocellular carcinoma.
J Cancer Res Clin Oncol. 1999 Dec;125(12):685-9. doi: 10.1007/s004320050334.

引用本文的文献

1
A decade's studies on metastasis of hepatocellular carcinoma.
J Cancer Res Clin Oncol. 2004 Apr;130(4):187-96. doi: 10.1007/s00432-003-0511-1. Epub 2003 Dec 18.

本文引用的文献

2
Genetic heterogeneity of hepatocellular carcinoma.
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):822-6. doi: 10.1073/pnas.91.2.822.
4
Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients.
Cancer. 1994 Jan 1;73(1):42-7. doi: 10.1002/1097-0142(19940101)73:1<42::aid-cncr2820730109>3.0.co;2-d.
5
Clonal origin of recurrent hepatocellular carcinomas.
Gastroenterology. 1989 Feb;96(2 Pt 1):527-9. doi: 10.1016/0016-5085(89)91581-3.
6
The p53 tumour suppressor gene.
Nature. 1991 Jun 6;351(6326):453-6. doi: 10.1038/351453a0.
7
p53 mutations in human cancers.
Science. 1991 Jul 5;253(5015):49-53. doi: 10.1126/science.1905840.
8
Mutational hotspot in the p53 gene in human hepatocellular carcinomas.
Nature. 1991 Apr 4;350(6317):427-8. doi: 10.1038/350427a0.
9
p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
Lancet. 1991 Nov 30;338(8779):1356-9. doi: 10.1016/0140-6736(91)92236-u.
10
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.
Nature. 1991 Apr 4;350(6317):429-31. doi: 10.1038/350429a0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验